Industry: Pharma & Healthcare
Published Date: 2025-03-13
Pages: 127 Pages
Report ld: 4662235
Request Sample
Customized Report
Dry Powder Inhalation Excipients Market Size(US$)

CAGR 2025-2031
5.4%
Market Size,2031
USD 2,491
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
North American market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Dry Powder Inhalation Excipients was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhalation Excipients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dry Powder Inhalation Excipients by region & country, by Type, and by Application.
The Dry Powder Inhalation Excipients market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhalation Excipients.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Dry Powder Inhalation Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Dry Powder Inhalation Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Dry Powder Inhalation Excipients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Dry Powder Inhalation Excipients Product Introduction
1.2 Global Dry Powder Inhalation Excipients Market Size Forecast
1.2.1 Global Dry Powder Inhalation Excipients Sales Value (2020-2031)
1.2.2 Global Dry Powder Inhalation Excipients Sales Volume (2020-2031)
1.2.3 Global Dry Powder Inhalation Excipients Sales Price (2020-2031)
1.3 Dry Powder Inhalation Excipients Market Trends & Drivers
1.3.1 Dry Powder Inhalation Excipients Industry Trends
1.3.2 Dry Powder Inhalation Excipients Market Drivers & Opportunity
1.3.3 Dry Powder Inhalation Excipients Market Challenges
1.3.4 Dry Powder Inhalation Excipients Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dry Powder Inhalation Excipients Players Revenue Ranking (2024)
2.2 Global Dry Powder Inhalation Excipients Revenue by Company (2020-2025)
2.3 Global Dry Powder Inhalation Excipients Players Sales Volume Ranking (2024)
2.4 Global Dry Powder Inhalation Excipients Sales Volume by Company Players (2020-2025)
2.5 Global Dry Powder Inhalation Excipients Average Price by Company (2020-2025)
2.6 Key Manufacturers Dry Powder Inhalation Excipients Manufacturing Base and Headquarters
2.7 Key Manufacturers Dry Powder Inhalation Excipients Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dry Powder Inhalation Excipients
2.9 Dry Powder Inhalation Excipients Market Competitive Analysis
2.9.1 Dry Powder Inhalation Excipients Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Dry Powder Inhalation Excipients Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Powder Inhalation Excipients as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Lactose
3.1.2 Magnesium Stearate
3.1.3 Others
3.2 Global Dry Powder Inhalation Excipients Sales Value by Type
3.2.1 Global Dry Powder Inhalation Excipients Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Dry Powder Inhalation Excipients Sales Value, by Type (2020-2031)
3.2.3 Global Dry Powder Inhalation Excipients Sales Value, by Type (%) (2020-2031)
3.3 Global Dry Powder Inhalation Excipients Sales Volume by Type
3.3.1 Global Dry Powder Inhalation Excipients Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Dry Powder Inhalation Excipients Sales Volume, by Type (2020-2031)
3.3.3 Global Dry Powder Inhalation Excipients Sales Volume, by Type (%) (2020-2031)
3.4 Global Dry Powder Inhalation Excipients Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 DPI
4.1.2 MDI
4.1.3 Nebulizer
4.1.4 Others
4.2 Global Dry Powder Inhalation Excipients Sales Value by Application
4.2.1 Global Dry Powder Inhalation Excipients Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Dry Powder Inhalation Excipients Sales Value, by Application (2020-2031)
4.2.3 Global Dry Powder Inhalation Excipients Sales Value, by Application (%) (2020-2031)
4.3 Global Dry Powder Inhalation Excipients Sales Volume by Application
4.3.1 Global Dry Powder Inhalation Excipients Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Dry Powder Inhalation Excipients Sales Volume, by Application (2020-2031)
4.3.3 Global Dry Powder Inhalation Excipients Sales Volume, by Application (%) (2020-2031)
4.4 Global Dry Powder Inhalation Excipients Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Dry Powder Inhalation Excipients Sales Value by Region
5.1.1 Global Dry Powder Inhalation Excipients Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Dry Powder Inhalation Excipients Sales Value by Region (2020-2025)
5.1.3 Global Dry Powder Inhalation Excipients Sales Value by Region (2026-2031)
5.1.4 Global Dry Powder Inhalation Excipients Sales Value by Region (%), (2020-2031)
5.2 Global Dry Powder Inhalation Excipients Sales Volume by Region
5.2.1 Global Dry Powder Inhalation Excipients Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Dry Powder Inhalation Excipients Sales Volume by Region (2020-2025)
5.2.3 Global Dry Powder Inhalation Excipients Sales Volume by Region (2026-2031)
5.2.4 Global Dry Powder Inhalation Excipients Sales Volume by Region (%), (2020-2031)
5.3 Global Dry Powder Inhalation Excipients Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Dry Powder Inhalation Excipients Sales Value, 2020-2031
5.4.2 North America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Dry Powder Inhalation Excipients Sales Value, 2020-2031
5.5.2 Europe Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Dry Powder Inhalation Excipients Sales Value, 2020-2031
5.6.2 Asia Pacific Dry Powder Inhalation Excipients Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Dry Powder Inhalation Excipients Sales Value, 2020-2031
5.7.2 South America Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dry Powder Inhalation Excipients Sales Value, 2020-2031
5.8.2 Middle East & Africa Dry Powder Inhalation Excipients Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value and Sales Volume
6.2.1 Key Countries/Regions Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.2.2 Key Countries/Regions Dry Powder Inhalation Excipients Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.3.2 United States Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.4.2 Europe Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.5.2 China Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.5.3 China Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.6.2 Japan Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.7.2 South Korea Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.8.2 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Dry Powder Inhalation Excipients Sales Value, 2020-2031
6.9.2 India Dry Powder Inhalation Excipients Sales Value by Type (%), 2024 VS 2031
6.9.3 India Dry Powder Inhalation Excipients Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Protheragen-ING
7.1.1 Protheragen-ING Company Information
7.1.2 Protheragen-ING Introduction and Business Overview
7.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Offerings
7.1.5 Protheragen-ING Recent Development
7.2 DFE Pharma
7.2.1 DFE Pharma Company Information
7.2.2 DFE Pharma Introduction and Business Overview
7.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Offerings
7.2.5 DFE Pharma Recent Development
7.3 Meggle-Pharma
7.3.1 Meggle-Pharma Company Information
7.3.2 Meggle-Pharma Introduction and Business Overview
7.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Offerings
7.3.5 Meggle-Pharma Recent Development
7.4 Pfanstiehl
7.4.1 Pfanstiehl Company Information
7.4.2 Pfanstiehl Introduction and Business Overview
7.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Offerings
7.4.5 Pfanstiehl Recent Development
7.5 Merck
7.5.1 Merck Company Information
7.5.2 Merck Introduction and Business Overview
7.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Merck Dry Powder Inhalation Excipients Product Offerings
7.5.5 Merck Recent Development
7.6 Sheffield (Kerry)
7.6.1 Sheffield (Kerry) Company Information
7.6.2 Sheffield (Kerry) Introduction and Business Overview
7.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Offerings
7.6.5 Sheffield (Kerry) Recent Development
7.7 Armor Pharma
7.7.1 Armor Pharma Company Information
7.7.2 Armor Pharma Introduction and Business Overview
7.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Offerings
7.7.5 Armor Pharma Recent Development
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Introduction and Business Overview
7.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Abbott Dry Powder Inhalation Excipients Product Offerings
7.8.5 Abbott Recent Development
7.9 Norvatis
7.9.1 Norvatis Company Information
7.9.2 Norvatis Introduction and Business Overview
7.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Norvatis Dry Powder Inhalation Excipients Product Offerings
7.9.5 Norvatis Recent Development
7.10 Bayer
7.10.1 Bayer Company Information
7.10.2 Bayer Introduction and Business Overview
7.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Bayer Dry Powder Inhalation Excipients Product Offerings
7.10.5 Bayer Recent Development
7.11 Jiangsu Daoning Drug
7.11.1 Jiangsu Daoning Drug Company Information
7.11.2 Jiangsu Daoning Drug Introduction and Business Overview
7.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Offerings
7.11.5 Jiangsu Daoning Drug Recent Development
8 Industry Chain Analysis
8.1 Dry Powder Inhalation Excipients Industrial Chain
8.2 Dry Powder Inhalation Excipients Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dry Powder Inhalation Excipients Sales Model
8.5.2 Sales Channel
8.5.3 Dry Powder Inhalation Excipients Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 99
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 124
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 92
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 133
USD 4350.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 117
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 99
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-08
Pages: 124
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 92
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 97
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published: 2025-01-01
Pages: 133
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-01
Pages: 91
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 117
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now